GlobeNewsWire · OCS · October 20, 2026

Oculis to Present Late-Breaking Phase 2 ACUITY Biomarker Analyses of Privosegtor in Optic Neuritis at the 10th Joint ACTRIMS-ECTRIMS Meeting

Get the app for more

Explore stock news, insights and company research.